Predict your next investment

Metabolon company logo
Corporation
HEALTHCARE | Biotechnology
metabolon.com

See what CB Insights has to offer

Executives

13

Board of Directors

4

Metabolon Board of Directors

4 Board of directors

Metabolon has 4 board of directors, including Carol Marino.

Name

Firm

Work History

Other Seats

Carol Marino

Carol joined Syngenta Ventures in 2009 as one of the founding members of the team. Prior to this she was Vice President Ventures Investments at Johnson & Johnson Development Corporation where her focus was on equity investments in pharmaceutical and biotech companies at all stages of development. Previous to this she held a number of senior positions at Clinical Development Capital LLC, a company which provides strategic investment capital to pharmaceutical companies for clinical development, Bristol-Myers Squibb Corporation and Merck & Co Inc. She serves as a director on the boards of Metabolon Inc. and the North Carolina Biotechnology Center. Carol holds a M.Sc. degree in Organic Chemistry from the University of New Hampshire, and a B.S. in Chemistry from Merrimack College.

Metabolon

Edward Erickson

Metabolon

Guy Fish

Metabolon

John Oxaal

At SRF, John focuses in areas of imaging, computing, photonics, RF communications, and Semiconductors. Before joining SRF in 1999, John co-founded and was CEO of Volumetrics Medical Imaging and was on the founding team of the Digital Signal Processing Division of Analog Devices. John holds several patents in the field of real-time volumetric ultrasound imaging. In addition to continuing as the Chairman of Volumetrics board, John serves on the boards of Astute Networks, Cadtel, Ethertronics, Luminescent, Luxtera, Metabolon, and Scintera. Other Details: Email jto@srfunds.com Events Semiconductor Technology: little room left for innovations? MicroVentures 2006 Portfolio Company News Astute Networks Named TechAmerica High Tech Awards Finalist Metabolon awarded series of patents Luxtera, Sun win Darpa optical IC contract GENBAND Nominated to Inc. 500 List of Fastest-Growing Private Companies Ethertronics Ranks on Inc. 500 List for Second Consecutive Year Embedded antennas demystified (ethertronics) Ethertronics buys Swedish antenna design group

Metabolon

Name

Carol Marino

Edward Erickson

Guy Fish

John Oxaal

Firm

Work History

Carol joined Syngenta Ventures in 2009 as one of the founding members of the team. Prior to this she was Vice President Ventures Investments at Johnson & Johnson Development Corporation where her focus was on equity investments in pharmaceutical and biotech companies at all stages of development. Previous to this she held a number of senior positions at Clinical Development Capital LLC, a company which provides strategic investment capital to pharmaceutical companies for clinical development, Bristol-Myers Squibb Corporation and Merck & Co Inc. She serves as a director on the boards of Metabolon Inc. and the North Carolina Biotechnology Center. Carol holds a M.Sc. degree in Organic Chemistry from the University of New Hampshire, and a B.S. in Chemistry from Merrimack College.

At SRF, John focuses in areas of imaging, computing, photonics, RF communications, and Semiconductors. Before joining SRF in 1999, John co-founded and was CEO of Volumetrics Medical Imaging and was on the founding team of the Digital Signal Processing Division of Analog Devices. John holds several patents in the field of real-time volumetric ultrasound imaging. In addition to continuing as the Chairman of Volumetrics board, John serves on the boards of Astute Networks, Cadtel, Ethertronics, Luminescent, Luxtera, Metabolon, and Scintera. Other Details: Email jto@srfunds.com Events Semiconductor Technology: little room left for innovations? MicroVentures 2006 Portfolio Company News Astute Networks Named TechAmerica High Tech Awards Finalist Metabolon awarded series of patents Luxtera, Sun win Darpa optical IC contract GENBAND Nominated to Inc. 500 List of Fastest-Growing Private Companies Ethertronics Ranks on Inc. 500 List for Second Consecutive Year Embedded antennas demystified (ethertronics) Ethertronics buys Swedish antenna design group

Other Seats

Metabolon

Metabolon

Metabolon

Metabolon

Metabolon Management Team

13 Team Members

Metabolon has 13 executives. Metabolon's founder is Paul R Schimmel. Metabolon's current Chief Executive Officer, President is Rohan Hastie.

Name

Work History

Title

Status

Rohan Hastie

Chief Executive Officer, President

Current

Michael Rasche

President

Current

Frank Fee

Chief Financial Officer

Current

Paul R Schimmel

Founder

Former

John A Ryals

President

Former

Name

Rohan Hastie

Michael Rasche

Frank Fee

Paul R Schimmel

John A Ryals

Work History

Title

Chief Executive Officer, President

President

Chief Financial Officer

Founder

President

Status

Current

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.